Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/20.500.12104/70743
Título : Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes
Autor: Grover-Paez, F.
Villegas Rivera, G.
Guillen Ortiz, R.
Fecha de publicación : 2007
Resumen : Sildenafil citrate has shown to display beneficial cardiovascular effects, suggesting that it may have other systemic benefits involving the endothelium. There is little data regarding the long-term use of this drug and the effects of this on different organs. Objective: The primary aim of this study was to determine whether sildenafil citrate diminishes concentrations of microalbuminuria and percentage of A1c in patients with type 2 diabetes. Design: A double-blind, randomized, controlled trial in 40 male patients, age 35-50, with type 2 diabetes. Subjects received sildenafil citrate 50 mg daily (n = 20) or placebo (n = 20) for 30 days. Levels of hs-CRP, microalbuminuria, homocysteine, A1c and erectile function were measured at baseline and to the end of the study. Results: Men that received sildenafil citrate displayed a significant decrease in the microalbuminuria concentrations (p < 0.01) versus baseline, (p = 0.02) versus placebo and A1c (p < 0.01) versus baseline, (p = 0.01) versus placebo. In addition, we observed a significant increase in the total IIEF score after 30 days of treatment (p < 0.01) versus baseline, (p < 0.01) versus placebo. Conclusions: The administration of 50 mg of sildenafil citrate for 30 consecutive days diminishes microalbuminuria and the percentage of A1c in patients with type 2 diabetes. © 2007 Elsevier Ireland Ltd. All rights reserved.
URI : http://hdl.handle.net/20.500.12104/70743
Aparece en las colecciones: Producción científica UdeG (prueba)

Ficheros en este ítem:
No hay ficheros asociados a este ítem.


Los ítems de RIUdeG están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.